SOPHiA GENETICS (SOPH) Cash & Current Investments (2020 - 2025)

SOPHiA GENETICS has disclosed Cash & Current Investments across 6 years of filings, most recently posting $70.3 million for Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $70.3 million, down 42.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $70.3 million (down 42.97% YoY), and the FY2025 annual result was $70.3 million, down 42.97% from the prior year.
• Cash & Current Investments came in at $70.3 million for Q4 2025 at SOPHiA GENETICS, down from $81.6 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $280.6 million in Q3 2021 to a low of $64.1 million in Q2 2021.
• The 5-year median for Cash & Current Investments is $123.3 million (2023), against an average of $147.1 million.
• Across the five-year window, Cash & Current Investments jumped 1452.69% in 2021 and tumbled 42.97% in 2025, its largest moves.
• SOPHiA GENETICS's Cash & Current Investments stood at $265.3 million in 2021, then slumped by 32.68% to $178.6 million in 2022, then slumped by 31.0% to $123.3 million in 2023, then changed by 0.0% to $123.3 million in 2024, then slumped by 42.97% to $70.3 million in 2025.
• The last three Cash & Current Investments figures came in at $70.3 million (Q4 2025), $81.6 million (Q3 2025), and $94.8 million (Q2 2025), per Business Quant data.